Nutrition Tips to Manage Side Effects Those taking GLP-1 medications might experience nausea, constipation, reflux, or early fullness, especially during dose changes
In addition to stimulating the release of insulin, GLP-1 agonists also appear to curb hunger and delay gastric emptying, leading to potential weight loss
Marston, Eastern District of Pennsylvania Number of Cases: Approximately 2,947 pending cases (and growing rapidly) Defendants: Novo Nordisk and Eli Lilly Covered Drugs: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Victoza, Saxenda, Trulicity Key Developments: August 15, 2025 - Landmark Ruling: Judge Marston ruled that gastroparesis claims require objective diagnostic testing (gastric emptying scan)
That molecule is L-Carnitine
Accessed April 1, 2023